2. As of noon trading, Onyx Pharmaceuticals ( ONXX) is down $3.27 (-2.5%) to $128.75 on heavy volume. Thus far, 2.5 million shares of Onyx Pharmaceuticals exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $128.30-$132.98 after having opened the day at $131.86 as compared to the previous trading day's close of $132.02. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. Onyx Pharmaceuticals has a market cap of $9.7 billion and is part of the health care sector. Shares are up 74.8% year to date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Onyx Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold. TheStreet Ratings rates Onyx Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. Get the full Onyx Pharmaceuticals Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.